2-(Methylthio)quinazolin-4-amine

Catalog No. :
ACBVSX045
CAS No. :
63963-40-6
Molecular Formula :
C9H9N3S
Molecular Weight :
191.26

IUPAC Name:2-(methylthio)quinazolin-4-amine

2-(Methylthio)quinazolin-4-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$63.00Login to see priceIn stockInquiry
1g95%$168.00Login to see priceIn stockInquiry
5g95%$587.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Methylthio)quinazolin-4-amine
IUPAC Name2-(methylthio)quinazolin-4-amine
MDL No.MFCD00799294
Molecular FormulaC9H9N3S
Molecular Weight191.26
SMILESCSC1=NC(N)=C2C=CC=CC2=N1
InChI KeyMXRPUVYQSUYFTH-UHFFFAOYSA-N
SynonymTIMTEC-BB SBB005541;LABOTEST-BB LT00441148;2-(Methylthio)quinazolin-4-aMine;2-(METHYLSULFANYL)-4-QUINAZOLINAMINE;4-AMINO-2-METHYLMERCAPTOQUINAZOLINE;4-AMINO-2-METHYLTHIO-QUINAZOLINE;4-AMINO-2-METHYLMERCAPTOQUINAZOLINE 97%;4-Amino-2-methylmercaptoquinazoline,97%
CAS No.63963-40-6
PubChem CID693785

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACBVSX045 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAZRI601 route compound structure diagram
    ACAZRI60159870-43-8 In Stock
  4. Then
  5. ACBVSX045 route product structure diagram
    ACBVSX04563963-40-6 In Stock
Inquiry

2. ACBVSX045 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Then
  5. ACBVSX045 route product structure diagram
    ACBVSX04563963-40-6 In Stock
Inquiry

Comments (0)